Back to Market Feed

Product Information

PERINDOPRIL ERBUMINE 8 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5440 per EA under NDC 65862028801. Its NADAC has been published 617 times since Nov 28, 2013.

FDA first approved this application on Nov 10, 2009.

PERINDOPRIL ERBUMINE 8 MG TAB

Perindopril Erbumine
$0.5440per EA

Strength

8 mg/1

NDC

65862028801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PERINDOPRIL ERBUMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA079070

FDA Approved

11/10/2009

On Market Since

11/10/2009

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for PERINDOPRIL ERBUMINE 8 MG TAB has been published 617 times since Nov 28, 2013, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5440 per EA
All-time high$0.6505 (Aug 14, 2019)
All-time low$0.4502 (Jan 22, 2020)
52-week high$0.6214
52-week low$0.5440
Median price$0.5437
Average price$0.5440
Largest weekly change+43.9% (Jul 17, 2019)
Weeks tracked617
Tracking sinceNov 28, 2013

Price History

1W

-1.4%

1M

-1.4%

3M

-5.2%

6M

-12.5%

1Y

-8.8%

3Y

+8.5%

5Y

+18.3%

All

+6.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Perindopril Erbumine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

LISINOPRIL 2.5 MG TABLET
Generic
00591040501•Actavis Pharma, Inc.
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
00591040505•Actavis Pharma, Inc.
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
23155087601•Heritage Pharmaceuticals Inc.
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
23155087605•Heritage Pharmaceuticals Inc.
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
31722017201•Camber Pharmaceuticals Inc.
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
31722017205•Camber Pharmaceuticals Inc.
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
43547035110•Solco Healthcare US LLC
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
43547035150•Solco Healthcare US LLC
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
43547041410•Solco Healthcare US LLC
$0.0142
per EA
LISINOPRIL 2.5 MG TABLET
Generic
43547041450•Solco Healthcare US LLC
$0.0142
per EA

Frequently asked questions

What is the NADAC price of PERINDOPRIL ERBUMINE 8 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for PERINDOPRIL ERBUMINE 8 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.5440 per EA (NDC 65862028801), effective Aug 19, 2026.

How has the price of PERINDOPRIL ERBUMINE 8 MG TAB changed over time?

Over the history we have for it, the NADAC for PERINDOPRIL ERBUMINE 8 MG TAB has risen 6.0%. It has been tracked across 617 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PERINDOPRIL ERBUMINE 8 MG TAB?

Since Nov 28, 2013, the NADAC for PERINDOPRIL ERBUMINE 8 MG TAB has ranged from a low of $0.4502 (Jan 22, 2020) to a high of $0.6505 (Aug 14, 2019), with a median of $0.5437 per EA.

Are there cheaper alternatives to PERINDOPRIL ERBUMINE 8 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of PERINDOPRIL ERBUMINE 8 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PERINDOPRIL ERBUMINE 8 MG TAB?

PERINDOPRIL ERBUMINE 8 MG TAB (NDC 65862028801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.